Actionable news
0
All posts from Actionable news
Actionable news in JUNO: JUNO THERAPEUTICS Inc,

Juno Therapeutics, Inc. director just disposed of 12,000 shares

Richard Klausner, a director of Juno Therapeutics, Inc., recently disposed of 12,000 shares of the company. The disposals took place at prices ranging from $42.79 to $43.51 per share, on April 15, 2016. Klausner still owns 870,799 shares of the company. Klausner operates out of Seattle, WA. Some additional info was provided as follows:

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2015, as amended August 14, 2015. This transaction was executed in multiple trades at prices ranging from $42.31 to $43.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of th e issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $43.31 to $43.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Juno Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Juno Therapeutics, Inc. releases salary data. CEO sees compensation fall -27% - April 20, 2016

Juno Therapeutics, Inc.'s General Counsel & Secretary just disposed of 3,200 shares - April 19, 2016
Juno Therapeutics, Inc. director just picked up 506 shares - April 7, 2016